Transient Suppression of Ligand-mediated Activation of Epidermal Growth Factor Receptor by Tumor Necrosis Factor-α through the TAK1-p38 Signaling Pathway*

Epidermal growth factor receptor (EGFR) has been shown to be activated by specific ligands as well as other cellular stimuli including tumor necrosis factor-α (TNF-α). In the present study, we found that cellular stress suppressed ligand-mediated EGFR activity. Both TNF-α and osmotic stress rapidly induced phosphorylation of EGFR. This phosphorylation of EGFR and the activation of mitogen-activated protein kinases and NF-κB occurred independently of the shedding of extracellular membrane-bound EGFR ligands and intracellular EGFR tyrosine kinase activity. Transforming growth factor-β-activated kinase 1 (TAK1) was involved in the TNF-α-induced signaling pathway to EGFR. In addition, experiments using chemical inhibitors and small interfering RNA demonstrated that p38α is a common mediator for the cellular stress-induced phosphorylation of EGFR. Surprisingly, the modified EGFR was not able to respond to its extracellular ligand due to transient internalization through the clathrin-mediated mechanism. Furthermore, turnover of p38 activation led to dephosphorylation and recycling back to the cell surface of EGFR. These results demonstrated that TNF-α has opposite bifunctional activities in modulating the function of the EGFR.

[1]  Y. Yarden,et al.  Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Peralta,et al.  The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity , 1997, The EMBO journal.

[3]  S. Winograd-Katz,et al.  Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of the EGF receptor , 2006, Oncogene.

[4]  J. Voorhees,et al.  Epidermal growth factor receptor is a critical mediator of ultraviolet B irradiation-induced signal transduction in immortalized human keratinocyte HaCaT cells. , 2006, The American journal of pathology.

[5]  H. Sakurai,et al.  Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv‐mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib , 2006, Cancer science.

[6]  Xuejun Jiang,et al.  Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. , 2006, Molecular cell.

[7]  E. Mekada,et al.  A Dual Signaling Cascade That Regulates the Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor* , 2001, The Journal of Biological Chemistry.

[8]  A. Motley,et al.  Clathrin-mediated endocytosis in AP-2–depleted cells , 2003, The Journal of cell biology.

[9]  Y. Yarden,et al.  p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy , 2006, The EMBO journal.

[10]  S. Akira,et al.  Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.

[11]  D. Lauffenburger,et al.  The Response of Human Epithelial Cells to TNF Involves an Inducible Autocrine Cascade , 2006, Cell.

[12]  A. Ullrich,et al.  GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways , 2005, Biological chemistry.

[13]  S. Higashiyama,et al.  ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. , 2005, Biochimica et biophysica acta.

[14]  H. Sakurai,et al.  Critical Roles of Threonine 187 Phosphorylation in Cellular Stress-induced Rapid and Transient Activation of Transforming Growth Factor-β-activated Kinase 1 (TAK1) in a Signaling Complex Containing TAK1-binding Protein TAB1 and TAB2* , 2005, Journal of Biological Chemistry.

[15]  J. Kartenbeck,et al.  Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol , 2002, Journal of cellular physiology.

[16]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[17]  K. Carraway,et al.  Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage , 2000, Oncogene.

[18]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[19]  G. Weskamp,et al.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.

[20]  S. Averbuch,et al.  Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors , 2004, British Journal of Cancer.

[21]  Y. Wan,et al.  EGF receptor crosstalks with cytokine receptors leading to the activation of c-Jun kinase in response to UV irradiation in human keratinocytes. , 2001, Cellular signalling.

[22]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[23]  H. Sakurai,et al.  Selective inhibition of TNF-α-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib , 2005, British Journal of Cancer.

[24]  A. Ullrich,et al.  EGFR signal transactivation in cancer cells. , 2003, Biochemical Society transactions.

[25]  Richard C Zangar,et al.  Induced Autocrine Signaling through the Epidermal Growth Factor Receptor Contributes to the Response of Mammary Epithelial Cells to Tumor Necrosis Factor α* , 2004, Journal of Biological Chemistry.

[26]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[27]  E. Mekada,et al.  ErbB and HB-EGF signaling in heart development and function. , 2006, Cell structure and function.

[28]  Michael D. Schneider,et al.  The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function , 2006, Nature Immunology.

[29]  M. Garcia-Lloret,et al.  Epidermal growth factor inhibits cytokine‐induced apoptosis of primary human trophoblasts , 1996, Journal of cellular physiology.

[30]  S. Tsai,et al.  Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants , 2006, Oncogene.

[31]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[32]  N. Hynes,et al.  ErbB receptors: directing key signaling networks throughout life. , 2004, Annual review of pharmacology and toxicology.

[33]  P. Dempsey,et al.  ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. , 2006, American journal of physiology. Cell physiology.

[34]  John Mendelsohn,et al.  The EGF receptor family as targets for cancer therapy , 2000, Oncogene.

[35]  Lee M Ellis,et al.  Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  G. Carpenter,et al.  Epidermal growth factor, its receptor, and related proteins. , 1986, Experimental cell research.

[37]  H. Sanjo,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[38]  W. Gullick,et al.  Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy. , 2006, European journal of cancer.

[39]  D. Barlow,et al.  Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells. , 2005, The Journal of clinical endocrinology and metabolism.

[40]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[41]  Robert J Coffey,et al.  EGF receptor ligands. , 2003, Experimental cell research.

[42]  G. Argast,et al.  Epidermal Growth Factor Receptor Transactivation Mediates Tumor Necrosis Factor-induced Hepatocyte Replication* , 2004, Journal of Biological Chemistry.

[43]  Michael Karin,et al.  Ultraviolet Light and Osmotic Stress: Activation of the JNK Cascade Through Multiple Growth Factor and Cytokine Receptors , 1996, Science.

[44]  R. Puertollano,et al.  Activation of p38 Mitogen-Activated Protein Kinase Promotes Epidermal Growth Factor Receptor Internalization , 2006, Traffic.

[45]  K. Irie,et al.  TAK1 Mediates the Ceramide Signaling to Stress-activated Protein Kinase/c-Jun N-terminal Kinase* , 1997, The Journal of Biological Chemistry.

[46]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[47]  P. Jänne,et al.  The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. , 2006, Cancer cell.

[48]  S. Anderson,et al.  Inhibition of Src Family Kinases Blocks Epidermal Growth Factor (EGF)-induced Activation of Akt, Phosphorylation of c-Cbl, and Ubiquitination of the EGF Receptor* , 2002, The Journal of Biological Chemistry.

[49]  H. Sakurai,et al.  TAK1‐mediated stress signaling pathways are essential for TNF‐α‐promoted pulmonary metastasis of murine colon cancer cells , 2006, International journal of cancer.